Friday 6 November 2026 Export RDNT’s income statement to Excel — free account

RadNet, Inc.

RDNT Healthcare Diagnostics & Research

RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.

Revenue: +25.0%
EPS: −47.4%
Free cash flow: −43.2%
Total debt: +21.2%

Quarter to June 2026, against a year earlier

75.25 2.76 −3.54%

Follow RDNT

Alert me

Market cap: $6.1B
P/E: 0.0×
Fwd P/E: 1,050×
Dividend yield: —
F-score: 3/9
Altman Z: 2.04
Beneish M: −2.62
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

RadNet, Inc. (RDNT) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, RadNet, Inc. (RDNT) trades at a price to free cash flow of 189×. Over the past ten years it has ranged from 0.0× (June 2024) to 1,739× (January 2025); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RDNT/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="RadNet, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RDNT/metrics/price-to-free-cash-flow">RadNet, Inc. (RDNT) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	120×	(92.83%)
FY2024	1,669×	74.11%
FY2023	959×	2,720.43%
FY2022	34.0×	(73.67%)
FY2021	129×	1,720.41%
FY2020	7.1×	(77.96%)
FY2019	32.2×	211.78%
FY2018	10.3×	80.19%
FY2017	5.7×	(36.77%)
FY2016	9.1×	(13.65%)

Period	Price to free cash flow	Change
Jun 2026	148×	111.84%
Mar 2026	70.1×	(41.47%)
Dec 2025	120×	(79.14%)
Sep 2025	574×	363.14%
42 more quarters	Free account

Against its own ten years

Low 0.0× High 1,739×

Ten-year median 15.1×

Current reading's percentile 91

Company	Price to free cash flow
GRAL GRAIL, Inc. compare	n/m
ADPT Adaptive Biotechnologies Corporation compare	n/m
VCYT Veracyte, Inc. compare	12.0×
ICLR ICON PLC compare	18.1×
QGEN QIAGEN N.V. compare	23.8×
SHC Sotera Health Company compare	33.5×
CDNA CareDx, Inc. compare	68.9×
BLLN BillionToOne, Inc. compare	156×
RDNT RadNet, Inc.	189×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

RadNet, Inc. (RDNT) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on RDNT

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on RDNT

Stockrow Weekly